Insider Transactions Reported by 25 Insiders of Evelo Biosciences, Inc.

Location
Foxboro, MA

There are no Buy or Sell transactions made by insiders since 24 Dec 2024

Evelo Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Flagship Pioneering Fund VII General Partner LLC 10%+ Owner $4.52M 27 May 2022
Flagship Ventures Fund IV General Partner LLC 10%+ Owner $2.62M 11 Jul 2023
Horizon Technology Finance Corp 10%+ Owner $714K 11 Jul 2023
David R. Epstein Director $31K 30 Jun 2022
Mark Bodmer CSO, President of R&D $8.49K 07 Nov 2023
Marella Thorell Chief Financial Officer $7.35K 07 Nov 2023
SIMBA GILL President & CEO, Director $5.86K 07 Nov 2023
Duncan McHale Chief Medical Officer $5.61K 07 Nov 2023
Mark Plinio Chief Commercial Officer $1.24K 31 Jan 2023
STEPHEN J. CARRIERE Principal Accounting Officer $67.00 19 Jan 2023
Juan Andres Director 08 Jun 2023
KYRIAZI THEO MELAS Director 08 Jun 2023
John Hohneker Director 08 Jun 2023
Jose-Carlos Gutierrez-Ramos Director 08 Jun 2023
Jonathan B. Zung Chief Development Officer 19 Jul 2022
DAVID P. PERRY Director 08 Jun 2021
Luca Scavo Cfo 19 Jan 2022
Ara Darzi Director 09 Jun 2022
Robert L. Rosiello Director 08 Jun 2023
Iain B. McInnes Director 08 Jun 2023
Jeffrey R. Moore Director 11 Jul 2023
Daniel Char General Counsel 19 Jul 2022
Tonya Williams Director 08 Jun 2023
Alexander C. Reynolds Director 11 Jul 2023
Julie McHugh Director 08 Jun 2023

Recent Insider Transactions by Companies or Individuals for Evelo Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.